MolecuLight i:X

MolecuLight i:X ™

 Wound Imaging Device

Using MolecuLight i:X for wound assessment with clinical signs and symptoms allows clinicians to safely and easily identify more wounds containing elevated bacterial burden (104 CFU/g), and measure wounds at the point-of-care.

Product Points

Easy icon

Easy

Portable, touch-screen with an intuitive interface.1,2

Safe icon

Safe

No contrast agents and no patient contact required.2

Precise icon

Precise

MolecuLight i:X improves the detection of wounds with elevated bacterial loads when combined with clinical signs and symptoms.

Efficient icon

Efficient

Using MolecuLight i:X, identifies more wounds with elevated bacterial load compared to clinical signs and symptoms alone enabling more efficient patient management.

Real-time icon

Point-of-Care

MolecuLight i:X provides information at the patient bedside to improve current evaluation by CSS.

Focused icon

Focused

Allows clinicians to focus on areas of the wound producing fluorescence.

Download Technical Specs

What does MolecuLight i:X do?

Detect Elevated Bioburden

MolecuLight i:X allows clinicians to focus on wounds containing elevated bacterial loads with the guidance of fluorescence imaging in combination with CSS.

Learn More

Measure Wound Area

MolecuLight i:X provides clinicians with a comprehensive toolkit for digital wound area measurement and documentation.

Learn More

Testimonials:
MolecuLight i:X in use

MolecuLight i:X - Making a difference in point of care wound treatment

Rosemary Hill, BSN, CWOCN, CETN(C)
Vancouver Coastal Health
North Vancouver, Canada

Watch Video

Run Time // 5:27

Swabbing and cost savings with MolecuLight i:X

Lt Col Steven Jeffery
The Royal Centre for Defence Medicine
Birmingham, UK

Watch Video

Run Time // 3:48

Accessories

MolecuLight
DarkDrape®

Portable dark environment for the MolecuLight i:X

Learn More

MolecuLight Woundstickers

For wound area measurement with the MolecuLight i:X Imaging Device.

Learn More

References

  1. DaCosta RS, Kulbatski I, Lindvere-Teene L, Starr D, Blackmore K, Silver JI, Opoku J, Wu YC, Medeiros PJ, Xu W, Xu L, Wilson BC, Rosen C, Linden R. Point-of-care autofluorescence imaging for real-time sampling and treatment guidance of bioburden in chronic wounds: first-in-human results. PLOS ONE, 2015, 10(2). doi: 10.1371/journal.pone.0116623.
  2. Chamma E, Qiu J, Lindvere-Teene L, Blackmore KM, Majeed S, Weersink R, Dickie CI, Griffin AM, Wunder JS, Ferguson PC, DaCosta RS. Optically-tracked handheld fluorescence imaging platform for monitoring skin response in the management of soft tissue sarcoma. Journal of Biomedical Optics, 2015, 20(7). doi: 10.1117/1.JBO.20.7.076011.
  3. Blumenthal E, Jeffery SLA. The use of the MolecuLight i:X in managing burns: a pilot study. Journal of Burn Care & Research, 2017, 39(1), 154-161. doi: 10.1097/BCR.0000000000000565.
  4. Raizman R. Fluorescence imaging positively predicts bacterial presence and guides wound cleaning and patient education in a series of pilonidal sinus patients. Presented at Wounds UK 2016. Proceedings of the Annual Wounds UK Conference; 2016 Nov 14-16; Harrogate, UK.
  5. Dunham D, Teene L. Objective wound measurement software on a point-of-care, hand-held fluorescence imaging device: verification of measurement accuracy and repeatability. Presented at EWMA 2018. Proceedings of the Annual European Wound Management Association Conference; 2018 May 9-11; Krakow, Poland.
  6. Wu YC, Smith M, Chu A, Lindvere-Teene L, Starr D, Tapang K, Wong O, Linden R, DaCosta RS. Handheld fluorescence imaging device detects subclinical wound infection in an asymptomatic patient with chronic diabetic foot ulcer: a case report. International Wound Journal, 2016, 13(4), 449-53. doi: 10.1111/iwj.12451.
  7. Ottolino-Perry K, Chamma E, Blackmore KM, Lindvere-Teene L, Starr D, Tapang K, Rosen CF, Pitcher B, Panzarella T, Linden R, DaCosta RS. Improved detection of clinically relevant wound bacteria using autofluorescence image-guided sampling in diabetic foot ulcers. International Wound Journal, 2017, 14(5), 833-841. doi: 10.1111/iwj.12717.
  8. Rennie MY, Lindvere-Teene L, Tapang K, Linden R. Point-of-care fluorescence imaging predicts the presence of pathogenic bacteria in wounds: a clinical study. Journal of Wound Care, 2017, 26(8), 452-460. doi: 10.12968/jowc.2017.26.8.452.
  9. Raizman R. Point-of-care fluorescence imaging device guides care and patient education in obese patients with surgical site infections. Presented at CAWC 2016. Proceedings of the Annual Canadian Association of Wound Care Conference; 2016 Nov 3-6, Niagara Falls, ON, Canada.
  10. Jeffery S. Utility of point-of-care autofluorescence imaging device in successful closure of major limb amputations – a case study. Presented at MHSRS 2016. Proceedings of the Military Health System Research Symposium; 2016 Aug 15-18; Kissimmee, FL, USA.